Clonidine Transdermal System Usp, 0.3 Mg/day Patch
Product Images NDC 52817-507

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Clonidine Transdermal System Usp, 0.3 Mg/day (NDC 52817-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton (0.1 mg)

Carton (0.1 mg)
This is a description of Clonidine Transdermal System. It comes in a pack of 4 systems and 4 adhesive covers, each containing 0.1 mg/day of medication. It is intended for transdermal use only. Please refer to the packaging for more information.*
FDA Label Image

Carton (0.2 mg)

Carton (0.2 mg)
FDA Label Image

Carton (0.3 mg)

Carton (0.3 mg)
This text appears to be a description of a Clonidine Transdermal System, USP, with a dosage of 0.3 mg/day. The product includes 4 systems and 4 adhesive covers, designed for programmed delivery of Clonidine over a week. The system is intended for transdermal use.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
This is a description of an adhesive cover that is intended to be applied over a patch if necessary. The cover is likely designed to provide protection and reinforcement to the patch when applied.*
FDA Label Image

Figure 2 Left (Figure 2a)

Figure 2 Left (Figure 2a)
FDA Label Image

Figure 2 Right (Figure 2b)

Figure 2 Right (Figure 2b)
This text is a warning label for an adhesive cover that does not contain active medication. It instructs the user to apply over the patch if necessary and refers to the patient information sheet for further details on usage.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
FDA Label Image

Figure 6 (Figure 6)

Figure 6 (Figure 6)
This is a warning label for an adhesive cover without active medication. It provides instructions to apply over the patch as necessary and refers to suggestions for use in the patient information sheet.*
FDA Label Image

Pouch (back) (0.1 mg)

Pouch (back) (0.1 mg)
This text provides instructions for removing a system containing medication from a pouch. It also includes information on storing the medication within the recommended temperature range. Additionally, the text mentions the distributor as TruPharma LLC located in Tempa, FL.*
FDA Label Image

Pouch (front) (0.1 mg)

Pouch (front) (0.1 mg)
This text provides information about a Clonidine Transdermal System, USP, delivering 0.1 mg of clonidine per day for one week. It warns to remove the system before undergoing an MRI procedure to prevent burns.*
FDA Label Image

Pouch (back) (0.2 mg)

Pouch (back) (0.2 mg)
This text provides instructions for removing a medication system from a pouch. It advises to tear there and remove the system. Additionally, it reminds to remove the clear backing before use and store the system at the recommended temperature range. The product is distributed by TruPharma LLC in Tampa, FL.*
FDA Label Image

Pouch (front) (0.2 mg)

Pouch (front) (0.2 mg)
This is a new Clonidine Transdermal System delivering 0.2 mg of clonidine per day for one week. It is essential to remove the system before undergoing an MRI scan to prevent potential burns.*
FDA Label Image

Pouch (back) (0.3 mg)

Pouch (back) (0.3 mg)
This text is a label or packaging information for a medication system contained in a pouch. It includes instructions to tear the packaging to remove the system and to remove the clear backing before use. Additionally, it provides storage instructions of storing the medication at a temperature between 20°C to 25°C (68°F to 77°F). The product is distributed by TruPharma LLC in Tampa, Florida.*
FDA Label Image

Pouch (front) (0.3 mg)

Pouch (front) (0.3 mg)
This is a new appearance of the Clonidine Transdermal System, USP, with a dosage of 0.3 mg/day. It is designed for programmed delivery in vivo of 0.3 mg clonidine per day for one week. It is important to remove the system before undergoing an MRI procedure to prevent possible burns.*
FDA Label Image

Clonidine Structure (Clonidine Structure)

Clonidine Structure (Clonidine Structure)
FDA Label Image

Company Logo (Company Logo 2)

Company Logo (Company Logo 2)
FDA Label Image

Company Logo (Company Logo 3)

Company Logo (Company Logo 3)
FDA Label Image
Company Logo (Company Logo)
FDA Label Image

Adhesive-cover (0.1 mg)

Adhesive-cover (0.1 mg)
This is a warning label for an adhesive cover that is not medicated. It is suggested to apply it over a patch if necessary. Additional instructions are available in the patient information sheet.*
FDA Label Image

Adhesive Cover (0.2 mg)

Adhesive Cover (0.2 mg)
This is a warning label for an adhesive cover that does not contain active medication and is meant to be applied over a patch if necessary. It advises users to refer to the patient information sheet for instructions on how to use the adhesive cover.*
FDA Label Image

Adhesive Cover (0.3 mg)

Adhesive Cover (0.3 mg)
This is an adhesive cover that is used without containing any active medication. It is meant to be applied over a patch if necessary, and user instructions can be found in the patient information sheet.*
FDA Label Image

Cross-section-table (Cross Section Table)

Cross-section-table (Cross Section Table)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.